Efficacy and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease

NCT04825886 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-02-06

No results posted yet for this study

Summary

This study is to evaluation the efficacy and safety of Zotarolimus-Eluting Stent in patients with long coronary artery disease of 25 mm or longer.

Conditions

Interventions

DEVICE

Zotarolimus-Eluting Stent

Percutaneous coronary intervention using zotarolimus-eluting stent

Sponsors & Collaborators

  • Chonnam National University Hospital

    lead OTHER

Principal Investigators

  • Youngkeun Ahn, MD · Chonnam National University Hospital

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-28
Primary Completion
2021-03-18
Completion
2022-03-18

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04825886 on ClinicalTrials.gov